ICCN 2023

Call for Abstracts

Call for Abstracts now open!

The theme for ICCN2023 is Building Global Nursing Excellence for Tomorrow’s Cancer Realities

ICCN2023 Objectives:

1. Provide a global forum for nurses caring for cancer patients to network and collaborate on current hot topics and future trends in cancer prevention and control in nursing practice.

2. Understand the impact, trends, and issues of cancer globally.

3. Examine the science, nursing practice and education to drive innovation within diversified global settings to build capacity for high quality person-centered care for people living with cancer.

4. Establish partnerships and global networks to rebuild, ignite and inspire all nurses as leaders in promoting and demonstrating equitable cancer care to reduce global health disparities.

Important Dates

Abstract Submission Opens December 1, 2022
Abstract Submission Deadline February 28, 2023 (23:59 BST)
Abstract Results Notification April 1, 2023
Presenting Author Registration Deadline June 30, 2023
Conference Dates September 29 – October 2, 2023
  1. Abstracts must represent original work.
  2. The abstract should not contain statements alluding to results or conclusions not presented in the text.
  3. Work should be completed and not “in progress”.
  4. Only abstracts identified as ‘complete’ in the submission system will be considered for review.
  • Abstracts are accepted in English only.
  • The maximum word limit for Abstract title is 10 words (excluding spaces)
  • The maximum word limit for Abstract text is 300 words
  • No images or tables allowed
  • Abstracts must be submitted through the submission portal
  • There can be only 1 Presenting Author.
  • The first author must be the Presenting Author
  • There is no limit to the number of co-authors.
  • Submitting an abstract does not register you for ICCN2023

Submission Limits:
A maximum of three oral presentations per Presenting Author will be accepted. Each submission must address a different abstract topic (regardless of presentation type)

Authors may select one of the following presentation types:

  1. Oral: A 10 – 15-minute oral presentation by the author(s) (maximum presentation is 15 minutes total)
  2. Poster: A visual display
  3. Any format (oral or poster) OR
  4. Instructional Session: A 75-minute session with a maximum of three presenters on a unified topic meant to instruct others. A coordinator/moderator may also be included and will be counted in the total number of presenters.

Format for Oral and Poster Abstracts:
Abstracts must contain brief but complete statements of:

  1. Purpose
  2. Background/Significance
  3. Project Description or Research Methods & Evaluation or Analysis
  4. Results/Findings/Outcomes
  5. Discussion and Implications, Impact and/or Usefulness

Format for Instruction Session:
Instructional Sessions must contain brief but complete statements of:

  1. Session Purpose
  2. Proposed Instructional Content
  3. Instructional Method(s)
  4. Relation of topic to conference theme
  5. Learning Objectives – minimum of 2
  6. Presenter Information – maximum of 3 presenters

Plenary Session Option:
A few abstract presentations may be selected to be part of a 90-minute plenary session

  • Clinical Practice Advancement
  • Continuum of CancerCare (from prevention to palliative)
  • Education/Professional Development
  • Leadership/Management
  • Policy/Advocacy
  • Research
  • Adolescent and Young Adult
  • Cancer care impacted by COVID19
  • Caregiver support/experience
  • Digital Health
  • Environmental Issues
  • Genomics
  • Gerioncology
  • Haemotology/Transplant
  • Models of Care/Workforce
  • Nursing Practice
  • Paediatric
  • Palliative Care and End-of-Life Care
  • Prevention and Screening
  • Psychosocial/QOL
  • Radiation Oncology
  • Solid Tumors
  • Surgical Oncology
  • Survivorship
  • Symptom Management
  • Other

All presenters must register for the Conference. Acceptance of abstracts for the conference program is contingent upon receipt of the registration fee. Notification of abstract acceptance will give presenters the opportunity to take advantage of the early bird registration fee.

Contact

If you have any questions regarding your submitted abstract or the abstract submission process, do not hesitate to reach out to iccn-program@icsevents.com

If your inquiry is regarding a particular draft or submission, please include the abstract ID in your email.